GO:0016600 flotillin complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016600 (flotillin complex) is a cellular_component term describing a protein complex that contains flotillin-1 and flotillin-2 and may contain associated proteins.
• Flotillins assemble into membrane microdomains that resemble caveolae and are implicated in membrane organization, endocytosis, and vesicle trafficking.
• The flotillin complex is a marker of extracellular vesicle subtypes and participates in ESCRT-independent exosome biogenesis.
• Autoantibodies against the flotillin-1/2 complex have been detected in patients with multiple sclerosis, linking the complex to neuroinflammatory disease.
• Flotillin complex components influence autophagosome-lysosome fusion and radiosensitivity in glioblastoma and protect the septic heart through LAMP2-FLOT2 interactions.
• Pathogens such as Anaplasma phagocytophilum hijack flotillin and NPC1 complexes to acquire intracellular cholesterol, revealing host-pathogen interfaces.
Description
The flotillin complex (GO:0016600) is a membrane-associated protein complex defined by the presence of flotillin-1 and flotillin-2, two homologous proteins that associate into microdomains resembling caveolae. This complex is a cellular_component in the Gene Ontology and has emerged as a key organizer of specialized membrane platforms involved in signal transduction, endocytosis, and vesicular trafficking. Understanding the flotillin complex is important because it represents a non-caveolar, cholesterol-dependent membrane scaffold that regulates diverse cellular processes, from extracellular vesicle biogenesis to autophagosome-lysosome fusion. Recent structural and proteomic studies have begun to reveal the architecture and interaction network of the flotillin complex in native membranes. The complex is not merely a static structural entity; it dynamically recruits associated proteins and lipids to coordinate membrane remodeling and cargo sorting. Its involvement in exosome secretion, pathogen entry, and disease-associated autoantibodies underscores its broad biological and clinical relevance. For researchers, GO:0016600 provides a precise annotation for studies of membrane microdomains, vesicle trafficking, and disease mechanisms. This article synthesizes authoritative QuickGO data and verified PubMed literature to outline the definition, composition, functions, disease links, and experimental approaches for investigating the flotillin complex.
flotillin complex At A Glance
| GO ID | GO:0016600 |
|---|---|
| GO term | flotillin complex |
| Ontology | cellular_component |
| Synonym | None |
| Major function | Membrane microdomain organization, endocytosis, vesicle trafficking, and signal transduction |
| Core components | Flotillin-1 (FLOT1) and flotillin-2 (FLOT2) |
| Associated proteins | May include proteins involved in exosome biogenesis, autophagy, and cholesterol transport |
| Membrane association | Associates with cholesterol-rich membrane microdomains resembling caveolae |
| Disease relevance | Multiple sclerosis, glioblastoma, septic heart injury, and host-pathogen interactions |
What Is GO:0016600?
According to the Gene Ontology, GO:0016600 (flotillin complex) is a protein complex that contains flotillin-1 and flotillin-2, and may contain associated proteins. Flotillins associate into membrane microdomains resembling caveolae. This definition captures the core heteromeric nature of the complex and its localization to specialized membrane domains.
Why Is flotillin complex Important in Cell Biology?
The flotillin complex is important because it defines a distinct class of membrane microdomains that operate independently of caveolin and regulate fundamental cellular processes such as endocytosis, exosome secretion, and autophagosome-lysosome fusion. Its role in extracellular vesicle subtype specification has made it a valuable marker in proteomic studies of exosomes and other vesicles. Moreover, the complex is directly implicated in human disease: autoantibodies against flotillin-1/2 are found in multiple sclerosis patients, flotillin complex components modulate radiosensitivity in glioblastoma, and LAMP2-FLOT2 interactions protect the septic heart. Pathogens also exploit flotillin complexes for cholesterol acquisition. Thus, GO:0016600 is a focal point for research at the intersection of membrane biology, vesicle trafficking, immunity, and disease.
• Defines a non-caveolar membrane microdomain platform that organizes signaling and trafficking.
• Serves as a marker for specific extracellular vesicle subtypes, aiding exosome research.
• Participates in ESCRT-independent exosome biogenesis through RAB31-associated pathways.
• Links to multiple sclerosis via autoantibodies against the flotillin-1/2 complex.
• Influences autophagosome-lysosome fusion and radiosensitivity in glioblastoma.
• Protects the septic heart through LAMP2-FLOT2 interaction in response to ILC2.
• Is hijacked by Anaplasma phagocytophilum for intracellular cholesterol acquisition.
• Provides a target for studying membrane microdomain assembly and protein-lipid interactions.
• Offers potential biomarkers for vesicle-based diagnostics and disease monitoring.
• Enables CRISPR-based functional studies of membrane trafficking and disease mechanisms.
What Happens During flotillin complex?
Assembly and Membrane Microdomain Formation
In simple terms: Flotillin proteins come together to form specialized patches on cell membranes.
Flotillin-1 and flotillin-2 associate into heteromeric complexes that partition into cholesterol-rich membrane microdomains resembling caveolae. Structural studies in native membranes reveal that the flotillin complex forms defined oligomeric assemblies that shape membrane curvature and serve as platforms for protein recruitment. This assembly is a prerequisite for the complex's downstream functions in trafficking and signaling.
Cargo Sorting and Endocytosis
In simple terms: The flotillin complex helps decide which molecules are taken into the cell and where they go.
Flotillin microdomains participate in endocytic pathways that are distinct from clathrin-mediated uptake. The complex recruits specific cargo and associated proteins to facilitate internalization and intracellular transport. Proteomic analyses have identified flotillin complex components in extracellular vesicle preparations, indicating a role in sorting cargo into vesicles.
Exosome Biogenesis and Vesicle Secretion
In simple terms: The flotillin complex is involved in making and releasing tiny vesicles called exosomes.
Flotillin complex components are enriched in specific extracellular vesicle subtypes and serve as markers for their characterization. RAB31 marks and controls an ESCRT-independent exosome pathway that involves flotillin-associated membrane domains. This pathway highlights how the flotillin complex contributes to vesicle formation and secretion independently of classical ESCRT machinery.
Autophagosome-Lysosome Fusion
In simple terms: The flotillin complex helps autophagosomes merge with lysosomes to degrade cellular waste.
The SDC1-TGM2-FLOT1-BHMT complex determines radiosensitivity of glioblastoma by influencing the fusion of autophagosomes with lysosomes. Similarly, LAMP2-FLOT2 interaction enhances autophagosome-lysosome fusion to protect the septic heart in response to ILC2. These findings establish the flotillin complex as a regulator of autophagic flux and lysosomal degradation.
Cholesterol Transport and Host-Pathogen Interactions
In simple terms: Some bacteria use the flotillin complex to steal cholesterol from host cells.
Anaplasma phagocytophilum hijacks flotillin and NPC1 complexes to acquire intracellular cholesterol for proliferation, a process that can be inhibited with ezetimibe. This demonstrates that the flotillin complex is a target for pathogen exploitation and a potential therapeutic intervention point.
Key Genes Involved in GO:0016600 flotillin complex
The following genes and proteins are central to the composition, regulation, and function of the flotillin complex (GO:0016600).
| Gene | Major Role | Research Relevance |
|---|---|---|
| FLOT1 | Core component of the flotillin complex; forms heteromers with FLOT2 | Structural studies, membrane microdomain assembly, disease models |
| FLOT2 | Core component of the flotillin complex; interacts with LAMP2 | Autophagy regulation, septic heart protection, vesicle trafficking |
| RAB31 | Marks and controls ESCRT-independent exosome pathway involving flotillin | Exosome biogenesis, vesicle subtype specification |
| SDC1 | Part of SDC1-TGM2-FLOT1-BHMT complex | Glioblastoma radiosensitivity, autophagy-lysosome fusion |
| TGM2 | Part of SDC1-TGM2-FLOT1-BHMT complex | Glioblastoma radiosensitivity, autophagy-lysosome fusion |
| BHMT | Part of SDC1-TGM2-FLOT1-BHMT complex | Glioblastoma radiosensitivity, autophagy-lysosome fusion |
| LAMP2 | Interacts with FLOT2 to enhance autophagosome-lysosome fusion | Septic heart protection, autophagy regulation |
| NPC1 | Cholesterol transport protein hijacked with flotillin by Anaplasma | Host-pathogen interactions, cholesterol acquisition |
| ILC2 | Group 2 innate lymphoid cells that signal in septic heart | Immune regulation of flotillin complex function |
| CD9 | Extracellular vesicle marker often co-isolated with flotillin | Vesicle subtype characterization |
| CD63 | Extracellular vesicle marker often co-isolated with flotillin | Vesicle subtype characterization |
| CD81 | Extracellular vesicle marker often co-isolated with flotillin | Vesicle subtype characterization |
| TSG101 | ESCRT component used to distinguish vesicle subtypes from flotillin | Exosome pathway comparison |
| ALIX | ESCRT-associated protein used in vesicle subtype proteomics | Exosome pathway comparison |
| Anaplasma phagocytophilum | Pathogen that hijacks flotillin and NPC1 | Infection biology, cholesterol acquisition |
| Ezetimibe | Inhibitor of cholesterol uptake that blocks Anaplasma proliferation | Therapeutic intervention in infection |
| Flotillin-1/2 autoantibodies | Autoantibodies against flotillin-1/2 complex in multiple sclerosis | Biomarker and disease mechanism studies |
How Is flotillin complex Regulated?
The flotillin complex is regulated at multiple levels. Its membrane association depends on cholesterol-rich microdomains, and structural studies show that the complex adopts defined conformations in native membranes. RAB31 controls an ESCRT-independent exosome pathway that involves flotillin-associated domains, indicating small GTPase regulation. In disease contexts, the SDC1-TGM2-FLOT1-BHMT complex modulates autophagosome-lysosome fusion and radiosensitivity, suggesting that associated proteins regulate flotillin complex function. LAMP2-FLOT2 interaction enhances autophagosome-lysosome fusion in response to ILC2 signaling, linking immune signals to flotillin complex activity. Pathogen-driven cholesterol acquisition also modulates flotillin complex trafficking.
flotillin complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FLOT1/FLOT2 | Multiple sclerosis autoantibody target | Patient-derived samples, autoantibody assays, KO cell models |
| FLOT1 | Glioblastoma radiosensitivity via SDC1-TGM2-FLOT1-BHMT | Glioblastoma cell lines with FLOT1 KO or point mutation |
| FLOT2 | Septic heart injury via LAMP2-FLOT2 interaction | Cardiomyocyte KO models, sepsis mouse models |
| FLOT1/FLOT2 | Host-pathogen cholesterol acquisition by Anaplasma | Infection models with flotillin KO cells, ezetimibe treatment |
| RAB31 | ESCRT-independent exosome pathway | RAB31 KO cells, vesicle proteomics |
Multiple Sclerosis and Neuroinflammation
Antibodies against the flotillin-1/2 complex have been identified in patients with multiple sclerosis, suggesting that the flotillin complex may be an autoimmune target in neuroinflammatory disease. This finding positions the complex as a potential biomarker and mechanistic contributor to multiple sclerosis pathology.
Glioblastoma and Radiosensitivity
The SDC1-TGM2-FLOT1-BHMT complex determines radiosensitivity of glioblastoma by influencing the fusion of autophagosomes with lysosomes. This links flotillin complex function to autophagy regulation and treatment response in brain tumors.
Septic Heart Injury
LAMP2-FLOT2 interaction enhances autophagosome-lysosome fusion to protect the septic heart in response to ILC2. This indicates that the flotillin complex plays a protective role in sepsis-induced cardiac dysfunction through autophagy regulation.
Host-Pathogen Interactions
Anaplasma phagocytophilum hijacks flotillin and NPC1 complexes to acquire intracellular cholesterol for proliferation, which can be inhibited with ezetimibe. This highlights the flotillin complex as a host factor exploited by pathogens and a potential therapeutic target.
From flotillin complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the structural architecture of the flotillin complex in native membranes? | Tagged knock-in of FLOT1/FLOT2 for cryo-EM or native membrane structural studies |
| How does flotillin complex loss affect exosome biogenesis? | FLOT1/FLOT2 knockout cells combined with vesicle proteomics |
| Does flotillin complex mutation alter autophagosome-lysosome fusion? | Point-mutation knock-in of FLOT1 or FLOT2 in glioblastoma or cardiomyocyte models |
| Can flotillin complex be targeted to block pathogen cholesterol acquisition? | FLOT1/FLOT2 knockout cells infected with Anaplasma, with ezetimibe treatment |
| What is the role of flotillin complex in multiple sclerosis autoimmunity? | Overexpression of FLOT1/FLOT2 in cell models for autoantibody binding assays |
| Which associated proteins regulate flotillin complex function? | Knock-in of tagged FLOT1/FLOT2 for interactome proteomics |
How to Study the flotillin complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM in native membranes | Structure of flotillin complex oligomers | Architectural studies of membrane microdomains |
| Proteomics of extracellular vesicles | Vesicle subtype composition and flotillin markers | Exosome characterization and biomarker discovery |
| RAB31 pathway assays | ESCRT-independent exosome biogenesis | Vesicle trafficking studies |
| Fluorescence microscopy | Autophagosome-lysosome fusion | Autophagy flux analysis in disease models |
| Co-immunoprecipitation | Protein-protein interactions within flotillin complex | Interactome mapping |
| Infection assays with Anaplasma | Cholesterol acquisition and pathogen proliferation | Host-pathogen interaction studies |
| Autoantibody detection assays | Anti-flotillin-1/2 antibodies in patient sera | Multiple sclerosis biomarker research |
| CRISPR knockout screens | Functional dependence on flotillin complex genes | Target discovery in cancer and immunity |
Structural Biology and Native Membrane Analysis
Structural studies of the flotillin complex in native membrane environments have provided insights into its oligomeric assembly and membrane interaction. High-resolution structures of human organellar SPFH protein complexes further reveal conserved architectural features. These methods are essential for understanding how flotillin complexes shape membrane microdomains.
Proteomics and Vesicle Characterization
Proteomic comparison of extracellular vesicle subtypes has defined flotillin complex components as markers for specific vesicle populations. RAB31-controlled ESCRT-independent exosome pathways can be dissected using proteomic and biochemical approaches. These techniques enable researchers to map the protein composition and cargo of flotillin-associated vesicles.
Functional Assays for Autophagy and Trafficking
Autophagosome-lysosome fusion can be assessed using fluorescence microscopy and biochemical assays in cells with flotillin complex perturbations. The SDC1-TGM2-FLOT1-BHMT complex and LAMP2-FLOT2 interaction provide specific readouts for autophagic flux. These functional assays link flotillin complex activity to cellular degradation pathways.
Infection and Cholesterol Transport Models
Anaplasma phagocytophilum infection models combined with flotillin and NPC1 perturbation allow study of cholesterol acquisition and pathogen proliferation. Ezetimibe inhibition provides a pharmacological tool to validate the pathway. Such models are valuable for host-pathogen interaction studies.
How CRISPR Can Be Used to Study GO:0016600 flotillin complex
Knockout
CRISPR knockout of FLOT1 or FLOT2 can abolish flotillin complex formation and reveal its role in exosome biogenesis, autophagy, and pathogen cholesterol acquisition. Knockout models are essential for loss-of-function studies of GO:0016600.
Point Mutation
Point mutations in FLOT1 or FLOT2 can disrupt specific interactions, such as LAMP2-FLOT2 binding, without eliminating the entire complex. Such models help dissect domain-specific functions of the flotillin complex.
Knock-in
Tagged knock-in of FLOT1 or FLOT2 enables visualization and affinity purification of the flotillin complex in native membranes. Knock-in of disease-associated variants can model altered complex behavior in multiple sclerosis or cancer.
Overexpression
Overexpression of FLOT1 or FLOT2 can amplify flotillin complex formation and enhance associated phenotypes, such as exosome secretion or autophagosome-lysosome fusion. Overexpression models are useful for gain-of-function studies and autoantibody binding assays.
How EDITGENE Supports flotillin complex Research
Researchers studying flotillin complex-related genes often need to determine whether a candidate gene is causally involved in membrane microdomain assembly, vesicle trafficking, or disease phenotypes. Rigorous functional validation requires precise genetic models that can isolate the contribution of individual components of GO:0016600.
Contact EDITGENE today to design your custom CRISPR model for flotillin complex research.
Frequently Asked Questions About flotillin complex
What is the flotillin complex?
The flotillin complex (GO:0016600) is a protein complex that contains flotillin-1 and flotillin-2 and may contain associated proteins; flotillins associate into membrane microdomains resembling caveolae.
What genes are involved in the flotillin complex?
The core genes are FLOT1 and FLOT2, which encode flotillin-1 and flotillin-2; associated proteins include RAB31, LAMP2, SDC1, TGM2, BHMT, and NPC1.
What is the function of GO:0016600?
GO:0016600 functions in membrane microdomain organization, endocytosis, vesicle trafficking, exosome biogenesis, and autophagosome-lysosome fusion.
Is the flotillin complex related to multiple sclerosis?
Yes, antibodies against the flotillin-1/2 complex have been found in patients with multiple sclerosis.
How is the flotillin complex involved in cancer?
The SDC1-TGM2-FLOT1-BHMT complex determines radiosensitivity of glioblastoma by influencing autophagosome-lysosome fusion.
What role does the flotillin complex play in exosomes?
Flotillin complex components are markers of specific extracellular vesicle subtypes and participate in RAB31-controlled ESCRT-independent exosome biogenesis.
Can pathogens exploit the flotillin complex?
Yes, Anaplasma phagocytophilum hijacks flotillin and NPC1 complexes to acquire intracellular cholesterol for proliferation.
What research methods are used to study the flotillin complex?
Methods include cryo-EM in native membranes, proteomics of extracellular vesicles, fluorescence microscopy for autophagy, co-immunoprecipitation, and CRISPR knockout screens.
What is the structure of the flotillin complex?
Structural studies in native membranes and of human organellar SPFH protein complexes have revealed the oligomeric architecture of the flotillin complex.
How does the flotillin complex protect the heart?
LAMP2-FLOT2 interaction enhances autophagosome-lysosome fusion to protect the septic heart in response to ILC2.
Conclusion
The flotillin complex (GO:0016600) is a specialized membrane microdomain assembly built on flotillin-1 and flotillin-2 that regulates endocytosis, exosome biogenesis, autophagy, and host-pathogen interactions. Its links to multiple sclerosis, glioblastoma, and septic heart injury make it a compelling target for both mechanistic and translational research. Continued structural, proteomic, and CRISPR-based studies will further clarify how this complex coordinates membrane biology in health and disease.
References
- 1. Fu Z et al.. 2024. Structure of the flotillin complex in a native membrane environment.. Proc Natl Acad Sci U S A 121(29):e2409334121 PMID: 38985763
- 2. Lleixà C et al.. 2023. Antibodies against the flotillin-1/2 complex in patients with multiple sclerosis.. Brain Commun 5(2):fcad109 PMID: 37091585
- 3. Kowal J et al.. 2016. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes.. Proc Natl Acad Sci U S A 113(8):E968-77 PMID: 26858453
- 4. Wei D et al.. 2021. RAB31 marks and controls an ESCRT-independent exosome pathway.. Cell Res 31(2):157-177 PMID: 32958903
- 5. Zeng L et al.. 2023. SDC1-TGM2-FLOT1-BHMT complex determines radiosensitivity of glioblastoma by influencing the fusion of autophagosomes with lysosomes.. Theranostics 13(11):3725-3743 PMID: 37441590
- 6. Shao R et al.. 2025. LAMP2-FLOT2 interaction enhances autophagosome-lysosome fusion to protect the septic heart in response to ILC2.. Autophagy 21(9):1888-1910 PMID: 40066518
- 7. Gao J et al.. 2025. Structures of human organellar SPFH protein complexes.. Nat Commun 16(1):10064 PMID: 41249155
- 8. Huang W et al.. 2021. Anaplasma phagocytophilum Hijacks Flotillin and NPC1 Complex To Acquire Intracellular Cholesterol for Proliferation, Which Can Be Inhibited with Ezetimibe.. mBio 12(5):e0229921 PMID: 34544283
